Deng Jianyuan, Wang Fusheng
Department of Biomedical Informatics, Stony Brook University.
Department of Computer Science, Stony Brook University.
AMIA Jt Summits Transl Sci Proc. 2020 May 30;2020:142-151. eCollection 2020.
Drug-drug interactions (DDI) can cause severe adverse drug reactions and pose a major challenge to medication therapy. Recently, informatics-based approaches are emerging for DDI studies. In this paper, we aim to identify key pharmacological components in DDI based on large-scale data from DrugBank, a comprehensive DDI database. With pharmacological components as features, logistic regression is used to perform DDI classification with a focus on searching for most predictive features, a process of identifying key pharmacological components. Using univariate feature selection with chi-squared statistic as the ranking criteria, our study reveals that top 10% features can achieve comparable classification performance compared to that using all features. The top 10% features are identified to be key pharmacological components. Furthermore, their importance is quantified by feature coefficients in the classifier, which measures the DDI potential and provides a novel perspective to evaluate pharmacological components.
药物相互作用(DDI)可导致严重的药物不良反应,并对药物治疗构成重大挑战。最近,基于信息学的方法正在兴起用于DDI研究。在本文中,我们旨在基于来自DrugBank(一个全面的DDI数据库)的大规模数据,识别DDI中的关键药理学成分。以药理学成分为特征,使用逻辑回归进行DDI分类,重点是寻找最具预测性的特征,即识别关键药理学成分的过程。使用以卡方统计量作为排名标准的单变量特征选择,我们的研究表明,前10%的特征与使用所有特征相比可实现相当的分类性能。前10%的特征被确定为关键药理学成分。此外,它们的重要性通过分类器中的特征系数进行量化,该系数衡量DDI潜力,并为评估药理学成分提供了一个新的视角。